These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15551277

  • 41. Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases.
    Cairoli R, Beghini A, Morello E, Grillo G, Montillo M, Larizza L, Morra E.
    Leuk Res; 2005 Apr; 29(4):397-400. PubMed ID: 15725473
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.
    Wei Y, Hardling M, Olsson B, Hezaveh R, Ricksten A, Stockelberg D, Wadenvik H.
    Ann Hematol; 2006 Dec; 85(12):841-7. PubMed ID: 17006667
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Successful induction of complete cytogenetic response with low-dose imatinib mesylate in an accelerated phase chronic myelogenous leukemia patient who developed severe bone marrow aplasia following standard-dose imatinib mesylate therapy].
    Nakazato T, Suzuki K, Mihara A, Sanada Y, Kakimoto T.
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):539-42. PubMed ID: 20332700
    [Abstract] [Full Text] [Related]

  • 47. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.
    Gallagher G, Horsman DE, Tsang P, Forrest DL.
    Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053
    [Abstract] [Full Text] [Related]

  • 48. Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
    Kako S, Kanda Y, Sato T, Goyama S, Noda N, Shoda E, Oshima K, Inoue M, Izutsu K, Watanabe T, Motokura T, Chiba S, Fukayama M, Kurokawa M.
    Am J Hematol; 2007 May; 82(5):386-90. PubMed ID: 17109389
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor beta-gene.
    Bastie JN, Garcia I, Terré C, Cross NC, Mahon FX, Castaigne S.
    Haematologica; 2004 Oct; 89(10):1263-4. PubMed ID: 15477214
    [Abstract] [Full Text] [Related]

  • 51. Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib.
    Abraham S, Salama M, Hancock J, Jacobsen J, Fluchel M.
    Pediatr Blood Cancer; 2012 Nov; 59(5):928-9. PubMed ID: 22488677
    [Abstract] [Full Text] [Related]

  • 52. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
    Payne SM, Kovacs MJ.
    Ann Pharmacother; 2004 Nov; 38(7-8):1215-8. PubMed ID: 15187212
    [Abstract] [Full Text] [Related]

  • 53. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.
    Magnusson MK, Meade KE, Nakamura R, Barrett J, Dunbar CE.
    Blood; 2002 Aug 01; 100(3):1088-91. PubMed ID: 12130532
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
    Shimomura Y, Maruoka H, Ishikawa T.
    Int J Hematol; 2017 May 01; 105(5):697-701. PubMed ID: 28000100
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Clonality as a criterion in the differential diagnosis of chronic neutrophilic leukaemia].
    Böhm J, Schaefer HE, Fisch P.
    Pathologe; 2002 Nov 01; 23(6):411-8. PubMed ID: 12436293
    [Abstract] [Full Text] [Related]

  • 60. Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy.
    Eskander RN, Tarsa M, Herbst KD, Kelly TF.
    J Obstet Gynaecol Res; 2011 Nov 01; 37(11):1731-3. PubMed ID: 21790885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.